62results about How to "Raise cholesterol levels" patented technology

The use of olive oil is described in the preparation of a product intended for oral hygiene, for example, a toothpaste, a mouthwash, a spray or oral inhaler or chewing gum, to eliminate or to reduce the bacterial plaque and/or bacteria present in the buccal cavity, achieving thereby a reduction in the occurrence of dental diseases (tooth decay, periodontal disease) and halitosis.

The present invention relates to oral compositions which are useful for nutrient supplementation. The dietary supplements and pharmaceutical products and methods of the present invention are particularly useful in the treatment of patients in various stages of chronic kidney disease and supplementing levels of physiological anti-oxidants, vitamins, and minerals in subjects requiring dialysis therapy.

The invention discloses a Camellia chrysantha herbal tea, and a production method thereof. The production method comprises extracting Camellia chrysantha leaf, Mesona chinensis, Morus alba leaf and Radix Glycyrrhizae with water, filtering, blending, fine filtering, filling, sterilizing, and cooling. The production method sufficiently retains trace elements, amino acids, polysaccharides, vitamins and other nutritional ingredients in Camellia chrysantha leaf; and has the effects of activating human cells, promoting metabolism, regulating balance of body functions, enhancing immunity, keeping healthy, clearing away toxic materials, relieving hangover, caring skin, relieving cough, reducing sputum, promoting salivation, reducing blood lipid, reducing blood pressure, and so on, in combination with Mesona chinensis, Morus alba leaf and Radix Glycyrrhizae.

A method for performing a medical procedure in an intestine of a patient is provided. The method comprises providing a system comprising: a catheter for insertion into the intestine, the catheter comprising: an elongate shaft comprising a distal portion; and a functional assembly positioned on the shaft distal portion and comprising at least one treatment element. The catheter is introduced into the patient, and target tissue is treated with the at least one treatment element. The target tissue comprises mucosal tissue of the small intestine, and the medical procedure can be configured to treat one or more diseases or disorders based on a measured physiologic parameter of the patient.

The invention discloses a novel application of an inhibitor for protein HSD17B13 or coding genes thereof. The novel application provided by the invention particularly means the application of the inhibitor for the protein HSD17B13 or the coding genes thereof in preparation of products for preventing and/or treating fatty liver. Proved by experiments, through immunizing a C57 wild-type mouse by using a recombinant adenovirus carrying an HSD17B13 gene, the condition that the liver of the mouse is subjected to obvious fatty change can be observed, oil red of a slice of the liver is stained and shows the accumulation of a lot of fat, and the content of triglyceride and cholesterol in liver tissues is increased remarkably, so that the HSD17B13 possibly participates in the formation process of fatty liver. The novel application has an important significance in prevention and/or treatment of fatty liver.

An exercise device for lower body includes a housing defining two compartments, a tread positioned within each compartment, and compression spring assemblies positioned within each compartment. Each tread is supported by and floats on top of its compression spring assembly.

The present invention relates to certain polyhydroxylated pentacyclic triterpene acids of formula (I) for use as HMG-CoA reductase inhibitors in the prophylactic and/or therapeutic treatment of a disease, disorder or condition that responds to a reduction of the HMG-CoA reductase activity in a mammal, preferably a human being. The present invention further relates to certain mixtures and plant extracts comprising euscaphic acid and tormentic acid, wherein the amount of euscaphic acid to tormentic acid exceeds a certain ratio. Further, the present invention also relates to a formulation, preferably pharmaceutical or nutraceutical formulation, comprising one or more of said compounds of formula (I), a composition according to the present invention or a plant extract according to the present invention. Also, the present invention relates to a process for obtaining certain polyhydroxylated pentacyclic triterpene acids of formula (I), a composition according to the present invention or a plant extract according to the present invention.

The invention relates to methods of treating or preventing obesity, type 2 diabetes, metabolic syndrome, or glucose intolerance using pyrido[3,2-e]pyrazines which are inhibitors of PDE10. The invention further relates to methods of reducing body fat or body weight.

Provided is a strain CCFM8630 of Bifidobacterium adolescentis and use thereof. The strain CCFM8630 of Bifidobacterium adolescentis can significantly increase neurotransmitter 5-hydroxytryptamine level in peripheral blood of rat, recover the hormone levels, for example testosterone and so on in peripheral blood of rat, normalize abnormal abundances of Bifidobacterium genus, Blautia genus and Turicibacter genus in intestinal flora of rat affected by high-fat high-starch diet, show pretty good tolerance to simulated gastrointestinal fluid and quickly colonize in intestinal, significantly improve pathological damages of tissues such as liver, duodenum and so on, and increase triglyceride and total cholesterol levels in serum and oral glucose tolerance of rat with metabolic syndrome caused by high-fat high-starch diet. The strain CCFM8630 of Bifidobacterium adolescentis can be used for preventing, relieving or treating metabolic disorder, such as metabolic syndrome, irritable bowel syndrome and mental diseases related to metabolic syndrome such as anxiety, depression and so on.

The invention relates to a gardenia total conjugate polyene composition, a preparation method thereof and application thereof to medicaments, and belongs to the field of the medicaments. According to tests, conjugate polyene compounds in gardenia have synergistic effect. Tumor resistance, hypertension resistance and hyperlipidemia resistance of the gardenia total conjugate polyene composition are higher than those of a control group and a single polyene compound such as crocetin and crocin. The preparation method of the gardenia total conjugate polyene composition is provided.

The invention provides a blood enriching Chinese traditional medicines. The medicine is made up of fleece-flower root, longan aril longan pulp and other Chinese traditional medicines according to the Chinese medical theory scientifically. The manufacturing method is: the fleece-flower root is produced into processed fleece-flower root, then it is blended with longan aril longan pulp, then they are processed into oral liquid, capsule, particle, tablet through water extraction and alcohol depositing. The medicine has functions of heart and spleen nourishing, qi and blood nourishing, upgrading the hemoglobin haemoglobin, increasing the quantity of erythrocyte, upgrading the HDL-C in high density fat protein, decreasing cholesterol, and preventing senescence. It can be applied to treat diseases caused by weak of heart and spleen, weak of qi and blood, the curative effect is prominent.

The invention discloses feed capable of promoting the molt of Penaeus vannamei and a preparation method thereof and belongs to the field of agricultural feed. The feed is prepared by mixing rice bran, bran, bean cake, minced fish meat, seaweed meal, squid liver paste, shrimp shell meal, salted duck egg, bile acid, radix astragali, Eucommia ulmoides, Adenophora stricta, radix rehmanniae preparata, dendrobium, fructus schizandrae, ginseng leaf, trace element agent and microbial fermentation agent and then performing fermentation. The feed has the advantages that the molting hormone of the Penaeus vannamei is increased by promoting the Penaeus vannamei to absorb the high cholesterol in the feed to synthesize ecdysterone so as to increase the molt and growth speed of the Penaeus vannamei; the feed can promote the molt of the Penaeus vannamei, increase the immunity of the Penaeus vannamei, increase the number of intestinal tract beneficial bacteria and purify water; drugs such as hormone and antibiotics are not added into the feed, and the feed is simple to prepare, safe in component, rich in nutrition, scientific in compatibility, good in feeding attraction performance and low in cost.

The invention mainly relates to the technical field of breeding, and discloses a method capable of improving egg yield of egg chickens. The method comprises the steps of reducing the density, controlling the nutrition, sterilizing for resistance to diseases and adjusting the environment; the method is simple, so that the egg yield is increased by 13.4%, the feed-egg ratio is reduced, the shell cracking rate of eggs is reduced to 0.8%, and the economic income of a farmer is increased by 10.7%; the breeding density of egg chickens is reduced, the motion range of the egg chickens is increased, the egg fragrance is aromatic, the content of cholesterol is reduced by 10.3%, heart and cerebral vessel health can be protected, and a hypertension patient can also eat the egg; before egg-laying maturity, fermented egg-shell meal is added into feed, so that egg shells are changed into wealth from waste, the feed after fermentation is beneficial to digestion and adsorption, a calcium element in the body is increased, forming of egg shells is promoted, the egg yield is increased, and the egg cracking rate is reduced; potable water is replaced every day, the digestion and the adsorption are promoted, other ingredients can provided rich vitamin and mineral elements, can also resist bacteria and inhibit bacteria, strengthen the disease-resistant ability, reduced the occurrence of diseases, and improve the egg yield.

The invention relates to human body immunity improvement antifatigue health food and a preparation method thereof, and overcomes the technical problems of taking inconveniences and poor effects of the prior art, the human body immunity improvement antifatigue health food comprises the following components: by weight, 10-20 parts of cordyceps polysaccharides, 10-20 parts of ganoderma lucidum polysaccharides, 10-20 parts of spirulina, 5-15 parts of medlar and 1-3 parts of propolis, the invention also provides the preparation method thereof, and the preparation method can be widely used in the foodstuff preparation field.

The invention discloses feed for laying hens. The feed is prepared from the following components in parts by mass: 30-40 parts of corn, 20-25 parts of wheat bran, 10-15 parts of soybean meal, 3-5 parts of fish powder, 2-4 parts of egg shell meal, 1-2 parts of bone powder, 1-2 parts of shell powder, 0.5-1 part of dried chili powder, 1-3 parts of pine needle meal, 5-10 parts of tea dust, 1-3 parts of sweet potato flour and 2-5 parts of foliums artemisiae argyi. According to the feed, the fish powder, egg shell powder, bone powder, shell powder, dried chili powder, pine needle powder and other powdered additives are added into ingredients, so that absorption of laying hens for foods can be effectively promoted, growth of laying hens can be effectively improved, and the laying rate can be improved; and the foliums artemisiae argyi added into the feed have an antibacterial effect, and the tea dust added into the feed can be used for increasing the content of cholesterol in eggs, so that the nutritional value of eggs can be greatly improved.

There is provided inter alia a compound of formula (I) or a pharmaceutically acceptable salt thereof and its use in therapy.

The present invention relates to a composition for preventing or treating hyperlipidemia, fatty liver disease or arteriosclerosis, comprising an oxyntomodulin derivative as an active ingredient. The oxyntomodulin derivative has a high ability to activate GLP-1 receptor and glucagon receptor compared to native oxyntomodulin and has the effects of reducing the blood total cholesterol, low-density cholesterol and triglyceride levels that were increased by high-fat diet, and increasing high-density cholesterol levels and the high-density cholesterol/low-density cholesterol ratio. Thus, the oxyntomodulin derivative can be effectively used for the treatment of hyperlipidemia and related diseases.

The invention belongs to the technical field of brewing and provides pure-grain avena sativa wine and a preparation method thereof. The pure-grain avena sativa wine and the preparation method thereof are used for solving the problems that high-quality avena sativa wine products are difficult in industrial production at present and the existing avena sativa wines are single in quality and odor type and cannot meet the taste requirements of customers. The pure-grain avena sativa wine is prepared from avena sativa, which serves as a main material, and red sorghum, barley and wheat, which serve as auxiliary materials, through brewing. The method comprises the steps of preparing a distiller's yeast, carrying out raw material treatment, carrying out fermentation, carrying out distillation wine extracting, and cellaring the obtained raw juice wine in a cellar. The pure-grain avena sativa wine is colorless and transparent, is free of suspended substances, is free of precipitates, is faint-scent and pure, has a full-bodied ethyl acetate fragrance and a special avena sativa grain fragrance, has a slight wheat fragrance and is comfortable in brewer's grain fragrance; the taste is lasting-sweet, refreshing and mellow and is sweet in aftertaste. The pure-grain avena sativa wine is rich in a variety of saccharide liquids derived from avena sativa fructose, thereby facilitating human body absorption and utilization, having the effect of alleviating postprandial blood sugar rise and being beneficial to the blood sugar control of diabetics; the pure-grain avena sativa wine can be used for improving a digestive function, promoting enterogastric peristalsis and alleviating constipation. The pure-grain avena sativa wine is used for lowering the cholesterol level of blood and improving immunity.

Methods for promoting healthy body weight and improving a variety of related physiological factors, including serum serotonin levels, serum leptin levels, fat oxidation, cholesterol levels, and body mass index, in persons or other mammals, include administering to those persons or other mammals effective amounts of hydroxycitric acid or a combination of hydroxycitric acid, chromium and gymnemic acid, which work synergistically to further to promote healthy body weight and improve these physiological factors.

The invention discloses beancurd skin with three delicacies for lowering internal-fire and a preparation method thereof. The beancurd skin with three delicacies is prepared from the following raw materials in parts by weight: 15-20 parts of mung beans, 30-40 parts of glutinous rice, 10-12 parts of shelled shrimp, 10-12 parts of globefish, 8-10 parts of broad beans, 5-10 parts of pears, 1-2 parts of aster altaicus, 3-5 parts of plant soot, 6-9 parts of rhinacanthus communis, 5-10 parts of tea fruit, 4-6 parts of scrophularia kakudensis fianch, 2-5 parts of cortex lycii radicis, 6-9 parts of licorice root, 4-8 parts of caulis aristolochiae manshuriensis, 5-9 parts of flabelate maiden-hair herb, 3-7 parts of gypsum rubrum and 1-2 parts of lotus leaf base. The beancurd skin with three delicacies has delicious, refreshing and smooth taste and attractive smell, is a popular flavor, and has an effect of lowering the internal-fire.

The invention discloses selenium-enriched edible mushroom biscuits. The selenium-enriched edible mushroom biscuits are made from the following raw material components in parts by weight: 100-200 parts of selenium-enriched edible mushrooms, 50-150 parts of isomaltulose, 5-10 parts of yeast, 700-780 parts of wheat flour, 3-5 parts of table salt and 2-6 parts of sodium bicarbonate. The selenium-enriched edible mushroom biscuits are rich in high-quality protein, and can have the effects of reducing blood cholesterol, maintaining normal blood sugar, increasing serum albumin and supplementing selenium through foods.

The invention discloses pork sausage. The pork sausage is made from, by weight, 500-510 parts of pork, 80-90 parts of pigskin, 20-22 parts of onion, 8-9 parts of red wine, 40-45 parts of pea, 5-6 parts of rhodiola rosea, 4-5 parts of centella asiatica, 5-6 parts of alpinia oxyphylla, 14-15 parts of salt, 8-9 parts of cinnamon powder, 12-14 parts of five spice powder and 0.9-1 part of capsorubin. Low-fat and high-protein pigskin replaces pig fat to be added to the sausage after being processed, the content of fat and cholesterol can be decreased, the content of protein in the product is increased, the influences that when fat is reduced, juicy sense and fragrance become weak can be reduced due to added corn oil, and the existing sensory quality of the sausage is kept; the sausage can be bright in color due to the added capsorubin, and meanwhile the shelf life of the sausage is prolonged; the pork sausage contains various Chinese herbal medicine ingredients and has the effect on strengthening brain.

A meat has a lowered amount of saturated fatty acid. By feeding a livestock animal with feed containing Lactobacillus plantarum BB-PLT (lactic acid bacterium BB-PLT strain) (NITE BP-02097), the saturated fatty acid contained in the meat from the livestock animal decreases and the monovalent unsaturated fatty acid contained in the meat from the livestock animal increases as a result of heating during cooking. The lactic acid bacterium strain Lactobacillus plantarum BB-PLT (NITE BP-02097) can be included in a livestock feed, and can be used in a method for raising a livestock animal for meat by feeding it to the livestock animal with the lactic acid bacterium. Edible meat can be obtained from a livestock animal raised by the method.

The present invention relates to a method for diagnosing higher susceptibility for diseases and conditions associated with low levels of AKG in a human or animal comprising the following steps: a) obtaining a biological sample from said human or animal; b) measuring the alpha-ketoglutaric acid (AKG) level in the biological sample; and c) comparing said measured AKG level with normal average AKG levels, wherein a level of AKG in said sample lower than an average level is indicative of a higher susceptibility for various diseases. Further the invention relates to a use of a substance comprising at least one member selected from the group consisting of AKG and derivates, metabolites, analogues or salts thereof for the manufacture of a pharmaceutical preparation or a food or feed supplement for the treatment or prophylaxis of diseases and conditions associated with low levels of AKG in a human or animal with low levels of AKG compared with normal average AKG levels.